Clinical Trial Update: Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test Antigen [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, false-positive reactions, and sensitizing properties of Leishmania tropica skin test antigen in cutaneous leishmaniasis; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Leishmania tropica skin test antigen

Snippet

Sponsor: Nielsen BioSciences, Inc. | Conditions: Cutaneous Leishmaniasis | Phase 2 | Status: COMPLETED | Results posted: 2012-12-06